Covered recipient · General Payments record
ANNA V KULCZYCKI MITTAG
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2021
$2,781.50
- Reported across 230 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $152.65 | 10 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $30.03 | 2 |
| Amgen Inc. | $29.67 | 2 |
| Merck Sharp & Dohme Corporation | $27.34 | 2 |
| Biohaven Pharmaceuticals, Inc. | $18.66 | 1 |
| PFIZER INC. | $17.54 | 1 |
| Astellas Pharma US Inc | $15.84 | 1 |
| Janssen Pharmaceuticals, Inc | $13.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.83 | 11/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 826295293 | CMS |
| Amgen Inc. | $14.84 | 12/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825148517 | CMS |
| Astellas Pharma US Inc | $15.84 | 12/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 821408479 | CMS |
| Biohaven Pharmaceuticals, Inc. | $18.66 | 11/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852542745 | CMS |
| Janssen Pharmaceuticals, Inc | $13.57 | 10/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788700719 | CMS |
| Lilly USA, LLC | $12.71 | 10/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818951147 | CMS |
| Lilly USA, LLC | $17.32 | 11/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818956631 | CMS |
| Merck Sharp & Dohme Corporation | $15.34 | 11/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848354145 | CMS |
| Merck Sharp & Dohme Corporation | $12.00 | 12/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848522915 | CMS |
| PFIZER INC. | $17.54 | 08/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832821081 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.